Abbott to pay up to .35 billion for arthritis drug - Chicago Tribune

Chicago Tribune

Abbott to pay up to .35 billion for arthritis drug Chicago Tribune Bloomberg Abbott Laboratories agreed to pay Galapagos NV as much as .35 billion for rights to an experimental rheumatoid arthritis drug that would compete with a Pfizer Inc. pill. North Chicago-based Abbott will pay Mechelen, Belgium-based Galapagos ... Abbott, Galapagos to develop rheumatoid arthritis therapyPharmaceutical Business Review Abbott to Pay Galapagos 0 Million Up Front for Arthritis Drug RightsBloomberg Galapagos Scores .35B Deal With Abbott for Arthritis DrugBioWorld Online Worcester Telegram -The Republic -Reuters all 77 news articles »

Steroid in RA Has Safe Effect on Glucose - MedPage Today

MedPage Today

Steroid in RA Has Safe Effect on Glucose MedPage Today Short-term treatment of early, active rheumatoid arthritis with high-dose prednisone did not lead to worsening of glucose tolerance, a Dutch study found. On an oral glucose tolerance test, the mean area under the curve for glucose did not change ...

Racing For A Cure Expands to Florida - San Francisco Chronicle (press release)

Racing For A Cure Expands to Florida San Francisco Chronicle (press release) Sheehan, 25, is a longtime runner who was recently diagnosed with rheumatoid arthritis. He is determined not to let his condition slow him down. "I want to be an endurance athlete," Sheehan said, "and I am not going to let rheumatoid arthritis stop me. and more »

Face of Juvenile Arthritis - London Community News

London Community News

Face of Juvenile Arthritis London Community News But nothing could be further from the truth as both of them suffer the chronic pain of Juvenile Rheumatoid Arthritis. To help raise the profile of the disease, March has been named Juvenile Arthritis Awareness Month. To this end, a number of events ... and more »